[CLDX] QoQ Quarter Result on 31-Dec-2012 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
08-Mar-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -11.85%
YoY- -32.01%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Revenue 980 97 2,414 3,647 3,113 2,009 2,433 -45.42%
PBT -23,140 -19,016 -17,332 -16,807 -15,027 -13,362 -13,083 46.20%
Tax -142 -161 -379 -94 -105 -252 -410 -50.65%
NP -23,140 -19,016 -17,332 -16,807 -15,027 -13,773 -13,516 43.06%
Tax Rate - - - - - - - -
Total Cost 24,120 19,113 19,746 20,454 18,140 15,782 15,949 31.72%
Ratio Analysis
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
NP Margin -2,361.22 -19,604.12 -717.98 -460.84 -482.72 -685.56 -555.53 162.16%
Per Share
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
EPS -4.28 -3.53 -3.51 -4.03 -3.79 -3.52 -4.04 3.91%
EPS Diluted -4.28 -3.53 -3.51 -4.03 -3.79 -3.52 -4.04 3.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.